Home / Pharma Healthcare / United States Thrombin Inhibitors Market Report 2016

United States Thrombin Inhibitors Market Report 2016

  • Id : RNR-14465
  • Category : Pharma Healthcare
  • Publish Date : 5-Oct
  • Pages : 117
  • Format : PDF
License Type

Description
Notes:

Sales, means the sales volume of Thrombin Inhibitors

Revenue, means the sales value of Thrombin Inhibitors



This report studies sales (consumption) of Thrombin Inhibitors in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

    Bayer AG

    Pfizer Inc

    Merck

    Sanofi

    Abbott Laboratories

    Johnson & Johnson

    Armetheon Inc

    Microbix Biosystems Inc

    Biovascular Inc

    Baxter International

    Astrazeneca

    Genentech

    Boehringer Ingelheim Gmbh

    Bristol-Myers Squibb CO

    CSL Behring

    ELI LILLY

    Emisphere Technologies

    Sun Pharmaceuticals

    Shire Pharmaceuticals



Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

    Argatroban

    Angiomax

    Iprivask

    Pradaxa

    Activase

    Retavase

    TNKase

    ATryn

Split by applications, this report focuses on sales, market share and growth rate of  Thrombin Inhibitors in each application, can be divided into

    Application 1

    Application 2

    Application 3